The same group 8 found that an a priori defined Mediterranean dietary pattern was associated with advantageous survival in a cohort of elderly people. Three other small studies have consistently reported similar results in Australia, 9 Spain 10 and Italy 11 using analogous methodologies. However, the outcome in all of these four studies included every cause of death and no information about the specific role of olive oil on CHD risk was reported.
A randomized secondary prevention trial conducted in France 12 showed an impressive protection provided by an experimental Mediterranean diet on the risk of death and reinfarction among survivors of a first acute myocardial infarction (AMI). Nevertheless, as the major element of the assigned diet was an experimental canola-oil based margarine and the diet simultaneously included a high intake of alpha-linolenic acid, fruit and vegetables, it was not possible to attribute its benefit to a single factor. In addition, the nutritional factors associated with primary and secondary prevention of CHD need not to be the same. The aim of our study was to assess the potential role of olive oil for the primary prevention of CHD and to quantify the reduction in the risk of a first AMI that can be provided by a high dietary olive oil intake.
Methods
Cases were defined as male or female subjects, aged under 80, survivors of a first AMI (ICD code 410) admitted to one of the three tertiary hospitals of Pamplona (Spain) within the periods October 1999-June 2000 or October 2000-February 2001. They had to fulfil the criteria 13 for definite AMI of the MONICA project (two or more ECG showing specific changes; ECG showing probable changes plus abnormal cardiac enzymes; or typical symptoms plus abnormal enzymes). A previous history of angina pectoris, a previous diagnosis of CHD or other prior diagnosis of major cardiovascular disease were exclusion criteria. Informed consent was obtained from the patients and the project was approved by the Institutional Review Board of the Medical School. We identified 180 eligible cases. Nine of them refused to participate (participation = 95%).
A control subject of the same age (5-year bands), gender and hospital was matched to each case. Eligible controls were patients admitted to the surgical, trauma or urology wards of the same hospital during the same month that matched cases for diseases believed to be unrelated to diet. Eight eligible controls refused to participate (participation: 96%) and each of them was replaced by other patients of similar characteristics for matching variables.
Cases and controls were interviewed in a standard way with the same questionnaire. All interviews were conducted by four physicians belonging to the research team (EFJ, EML, MP, CB). The same physician who interviewed a case patient also interviewed the respective matched control. The physicians had to exclude cases with a previous history of angina or other cardiovascular symptoms. Therefore, they were not blinded to the participant's disease status. The physician approached the patients, invited them to participate and provided them with the selfadministered questionnaire. It included a semi-quantitative food-frequency questionnaire (118 food items), previously validated in Spain, 14 that was slightly expanded for this study (136 items plus vitamin supplements). For each food item, a commonly used portion size was specified, and participants were asked how often they had consumed that unit on average over the previous year. Emphasis was added to ensure that the answers were related to long-term dietary exposures and not to recent changes in diet. Nine options for frequency of consumption were possible. The type of fat used in frying was specifically assessed. A dietitian updated the nutrient data bank using the latest available information included in the food composition tables for Spain. Total energy-adjusted intakes were computed using the residuals method. 15 The participants were asked to report their usual time spent practising the following activities: walking, jogging, running, athletics, cycling, swimming, racquet sports, soccer, team-sports other than soccer, dancing, aerobics, hill-walking, climbing, gardening, skiing, skating, fishing, martial arts, and watersports. To quantify the volume and intensity of leisure-time physical activity, we computed an activity metabolic equivalent (MET) index by assigning a multiple of resting metabolic rate (MET score) to each activity. It was multiplied by the weekly time spent in each activity obtaining a value of overall weekly METhours. 16 This measurement represents both the amount and relative intensity of physical exercise during a week for each participant. Five cases did not personally answer the questionnaire, and we used the answers given by a relative. We used the same procedure for matched controls.
The physician clarified any questions the patient may have had in completing the questionnaire, and subsequently the physician conducted a face-to-face interview about his or her coronary risk factors (smoking, diabetes, high blood pressure, high blood cholesterol, recent weight changes) and family history of cardiovascular disease. The physician took systolic and fifth-phase diastolic blood pressure readings and measured weight and height according to a standardized protocol, with the subject barefoot and dressed in light clothing. For each participant we calculated the body mass index (BMI) as the weight in kilograms divided by the squared height in metres (kg/m 2 ).
Most cases (166/171) were interviewed in the cardiology ward once they had been discharged from the coronary unit. Two of them were interviewed at their homes after being discharged from the hospital. All control subjects were interviewed in hospital wards, except one who was interviewed at home.
The association of olive oil consumption with myocardial infarction was calculated through conditional logistic regression using matched data of 171 case-control pairs. Quintiles of olive oil intake defined according to the distribution among controls were compared regarding several potential confounding variables. First, we fitted models using crude olive oil intake (unadjusted for total energy intake) as the independent variable. Then we used energy-adjusted values of olive oil. 15 Potential confounders were introduced in two steps in both multivariable models. First, we introduced non-dietary confounders. In a second model we also added the dietary confounders. Quadratic terms for some confounders, including ethanol, were used to account for non-linear relationships. We selected confounders by taking into account previous published literature about coronary risk factors and avoided the reliance on P-values or stepwise approaches. Tests for trend were done using the median of each quintile as a continuous variable. Reported P-values are two-tailed; values Ͻ0.05 were considered significant.
Results
The average daily intake of olive oil was 22.8 g (SD: 19.9) in women and 25.3 g (SD: 18.0) in men. The total energy-adjusted mean was 24.9 for both genders. Thus, the slightly higher absolute intake among men was explained by their higher energy intake.
The distribution of socio-demographic variables was similar in cases and controls (Table 1) . Nevertheless, a slightly higher proportion of cases than controls had a university degree, whereas a higher proportion of controls than cases were working in qualified non-manual jobs (i.e. 'white collar'). As expected, cases were more likely to be current smokers, have a higher BMI, prior history of hypertension, diabetes or high blood cholesterol. Also as expected, leisure-time physical activity was higher among controls. Most case-control differences in the crude mean intake of nutrients were not statistically significant, and in general, they were small.
The cut-off points for the quintiles of energy-adjusted olive oil intake were 10.4, 17.6, 21.2 and 37.9 g/day in the whole sample and 11.4, 18.2, 24.6 and 40.7 g/day among controls. The mean paired difference in the intake of energy-adjusted olive oil between cases and controls was -1.4 g/day (higher intake among controls). Table 2 shows the distribution of potential confounding variables across quintiles of energy-adjusted olive oil intake among control subjects. A higher proportion of married subjects, of those with prior history of diabetes and of current smokers was found among those with a higher energy-adjusted olive oil intake. A higher mean ethanol intake was also associated with a higher olive oil intake. The intake of some nutrients previously reported to be inversely associated with CHD, such as total dietary fibre, 17 folic acid, 18 vitamin B6, 18 and vitamin C, 19 was significantly lower among those controls with greater energy-adjusted olive oil consumption. A lower glycaemic load 20 was found in the highest quintile of olive oil consumption, but the trend was not statistically significant.
When we used the quintiles of olive oil intake without energy-adjustment as the exposure variable (Table 3) , the point-estimates for the OR were lower than 1 in the three upper quintiles of olive oil intake. Exposure to the upper quintile of olive oil was associated with a relative risk reduction of 64% (OR = 0.36, 95% CI : 0.12-1.08) with respect to the first quintile (median intake: 7.2 g/day). The linear trend test was in the limit of statistical significance when we adjusted for smoking (four categories), BMI (continuous variable, adding a quadratic term to account for non-linearity), high blood pressure, high blood cholesterol, diabetes, leisure-time physical activity (METS-h/week, continuous variable, adding a quadratic term), marital status, occupation and educational level (four categories). Further adjustment for other nutrients (saturated fat, trans fat and total fibre intake as continuous variables) led to statistically significant results with OR = 0.26 (95% CI : 0.08-0.85) for the upper quintile and P = 0.02 for the linear trend test.
We also fitted conditional logistic regression models using energy-adjusted intake of olive oil as the exposure variable ( Table 4 ). The risk reduction was then more apparent. We found point-estimates lower than 1 for the OR in the four upper quintiles of energy-adjusted olive oil intake and a significant linear trend test either when we adjusted only for non-dietary confounders (P = 0.03) or also for relevant nutrients (P = 0.03). The relative reduction in the risk of a first myocardial infarction was greater than 75% for the upper quintile, OR = 0.22 (95% CI : 0.07-0.67) after adjusting for non-dietary confounders and OR = 0.18 (95% CI : 0.05-0.63) after adjustment for dietary and non-dietary confounders.
When we excluded diabetic subjects (28 cases and 13 controls) and fitted a multivariate unconditional logistic regression model (adjusting for age and gender in addition to the variables shown in the first footnote of Table 4 ) the odds ratio for the upper quintile of energy-adjusted olive oil intake was 0.45 (95% CI : 0.23-1.00, P Ͻ 0.05). When we excluded case and control subjects with previous history of high blood cholesterol (total cholesterol Ͼ240 mg/dl, 21 cases and 15 controls), the adjusted OR for the highest quintile of energy-adjusted olive oil intake was 0.12 (95% CI : 0.03-0.54).
Discussion
To our knowledge this is the first analytical epidemiological study finding direct evidence supporting an important protective effect of olive oil against a first AMI. The protective role for olive oil is firmly consistent with many international comparisons of CHD mortality and incidence rates. Very low rates of CHD have usually been found in countries where olive oil consumption is higher. 21 Our results can be also explained according to several plausible biological mechanisms. In comparison with saturated fatty acids, olive oil reduces low-density lipoprotein (LDL) cholesterol, 22 and compared with carbohydrates, it maintains or even increases the levels of high-density lipoprotein (HDL) cholesterol. 23 In addition, it is relatively resistant to oxidation and contains a large amount of antioxidants relative to its polyunsaturated fat content. 24 Some polyphenol constituents of olive oil (hydroxytirosol and oleuropein) are potent scavengers of superoxide radicals 25 and inhibit LDL oxidation. 26 Olive oil has induced a regression of atherosclerosis in animal models 27 and may slow the development of coronary atherosclerosis, being associated with a reduced DNA synthesis in human coronary smooth muscle cells. 28 A recent trial showed OLIVE OIL CONSUMPTION AND MYOCARDIAL INFARCTION 477 that olive oil significantly improved endothelial function in hypercholesterolaemic men. 29 Olive oil also favourably affects postprandial factor VII activity, avoiding a prolonged thrombotic response to a high-fat diet. 30, 31 A beneficial effect of MUFA on the endothelium and von Willebrand factor, 32 as well as other benefits of olive oil on the haemostatic system 33 have been recently suggested. In diabetic patients, olive oil improves the lipid profile 34 and glycaemic control. 35 The potential cardiovascular benefits purportedly attributed to olive oil in diabetics led us to include them as eligible either as cases or controls in our study.
A randomized trial showed that olive oil markedly lowered blood pressure and reduced daily antihypertensive dosage requirement among hypertensive subjects. 36 Therefore, many roads may lead from olive oil intake to a lower risk of a first AMI, increasing the likelihood of a causal association.
In addition to the contrast of our results with the negative findings reported from previous studies, 5-7 some other inconsistencies must also be acknowledged. For example, the decreasing CHD mortality and the decreasing average per capita consumption of olive oil in Spain (and other Mediterranean countries) during the last three decades show secular trends that are in sharp contrast with the protective hypothesis for olive oil that our data support. 37 However, mortality data depend not only on incidence rates, but also on medical care of CHD patients, which is very likely to have improved during these decades in Spain and other Mediterranean countries.
Several limitations of our study which might be alternative explanations to our findings must be acknowledged. Our sample size was not very large. At the design stage, the study size was calculated assuming an alpha error = 0.05, and 80% power to detect OR у2.0 with a 20% probability of exposure among controls and that the exposure correlation between case and control subjects would be less than 0.45. 38 If this correlation were 0.3 (as was the actual case in our study), the power would be 90%. Subsequently, we have used the comparison among extreme quintiles, thus reducing the statistical power. We chose to focus on this comparison between extreme quintiles because it is very unlikely that it would lead to misclassification due to measurement error. 39 Although the magnitude of the relative effect was large (relative risk reduction Ͼ75%), we were approaching the limits of statistical significance. However, after adjustment for total energy intake and several known confounders, the inverse association with olive oil intake was still apparent.
Our design is susceptible to being affected by recall bias. However, recall bias is more likely to happen when differential over-reporting exists in cases, because they may be more aware of the greater risk associated with publicly known determinants of disease. This is unlikely to occur when assessing the intake of protective factors (olive oil in our study). Moreover, when the assessment of exposure is done via different items in a comprehensive questionnaire, such as in this case, it would be more difficult for a patient to consistently underestimate his/her exposure to olive oil. Although the in-hospital selection of controls facilitates higher participation, it also imposes some caution in the interpretation of findings because the exposure may be related to the diseases causing the hospital admission of controls. Olive oil has not been found to induce any trauma or genitourinary disease or any common disease needing minor surgery. Thus, it is very unlikely that our findings could be alternatively explained by selection bias due to an association between olive oil exposure and a higher probability of being admitted to a hospital with these diagnoses.
Although the mean of energy expenditure was slightly higher among controls than cases, we found no statistically significant association of energy expenditure (METS-hours/weeks) with the risk of myocardial infarction (P = 0.21 for the linear trend test). In previous epidemiological studies a higher caloric intake was usually protective. One of the most consistent findings of prospective studies about diet and CHD is a strong inverse association between total energy intake and CHD. 40 However, as some of our control patients were bedridden and had limited physical activity, it is not surprising that we missed this association.
An inherent limitation of a case-control design is that some fatal cases may be lost for the case series if they are fatal early on. Thus, the observed results would be compatible with olive oil having no effect on risk of myocardial infarction but an effect on chance of survival. However, this potential bias would require impossible assumptions to explain our results. For example, an incredibly high adverse effect of olive oil on survival, in the range of an early mortality OR Ͼ100 (fifth versus first quintile) would be needed to explain the OR found for the fifth quintile. Therefore, the alternative explanation that the observed inverse association with non-fatal infarction was due to poorer survival caused by olive oil seems extremely unlikely.
The possibility that people with first myocardial infarction may have been aware of early symptoms and have made more recent changes to their diet was explicitly addressed in the a Conditional logistic regression (age-, hospital-and gender-matched pairs), adjusted for smoking, body mass index, high blood pressure, high blood cholesterol, diabetes, leisure-time physical activity (METS-hours/week), marital status, occupation and study level. b Additionally adjusted for % energy derived from saturated fat, % energy derived from trans fat, total fibre consumption, folic acid intake, vitamin C intake, glycaemic load and ethanol intake (adding a quadratic term to account for non-linearity).
design stage. To avoid it, we made the decision to exclude cases with previous symptoms (angina or other cardiovascular manifestations) and used physicians as interviewers to carefully screen case patients and exclude those with any previous symptom predating the infarction. We also interviewed patients as soon as possible after the acute event to prevent this bias. Moreover, this bias would tend to diminish the association if people with myocardial infarction had recently increased their consumption of olive oil. The precautions we took to prevent this bias might help to explain the divergence of our results with two previous casecontrol studies conducted in Mediterranean countries which found no association for MUFA intake 5 or for oils consumption. 7 Another potential concern is represented by the fact that the physicians who carried out the interviews were not blind to the case-control status of the patient. However, this fact is very unlikely to have caused a serious bias in our estimates of the effect of olive oil consumption on AMI risk because the foodfrequency questionnaire was self-administered. The interviewing physician did not ask any questions of the patient regarding the consumption of olive oil, but simply provided him/her with the self-administered questionnaire, and the patient completed the questionnaire by himself/herself.
Food-frequency questionnaires have become the primary method for measuring dietary intake in epidemiological studies. 41 Although the food-frequency questionnaire used in this study was specifically validated in Spain against dietary records, 14 and dietary records are likely to have the least correlated errors, 39 we acknowledge that this instrument might have misclassified participants at some level regarding their olive oil consumption. Because olive oil is widely used in cooking and on foods, it may be difficult to quantify accurately. A trained dietitian (CF) with special expertise in nutritional epidemiology reviewed the major available sources of information about oil use in Spain in order to make the calculations and derive the total intake of olive oil from the answers to the food-frequency questionnaires. However, measurement error always exists in nutritional epidemiology and it usually introduces nondifferential exposure misclassification. 42 It is commonly believed that non-differential misclassification of a exposure predictably biases the OR towards the null value. Nevertheless, sometimes, when the exposure has more than two categories, this bias can be away from the null value. 43 This possibility might result in an alternative explanation to our results, but would be unusual. Moreover, it has been shown that measurement error is very unlike to misclassify individuals from one extreme quintile into the other extreme 39 because much of the measurement error probably concentrates in the middle categories. 42 The strongest association we found was precisely for the comparison between extreme quintiles.
The degree of between-subject variability in the intake of a particular nutrient or food item in the population under study is a strong determinant of the ability of a study to detect an association between that nutrient and CHD. A higher level of consumption of a food item is usually associated with higher between-subject variability. This has been the case in our findings with a wide contrast of consumption between extreme quintiles (medians = 7 versus 54 g/day). Therefore, the very high levels and the heterogeneity of olive oil consumption found in Spain are advantages of our study and may explain why we have found such a strong association. However, because of the inconsistency with previous studies (and the inherent limitations of our design), further epidemiological studies, preferably following a cohort instead of a case-control design, and also trials are needed in Mediterranean countries to confirm our findings.
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KEY MESSAGES
• A wide variety of physiological reasons support that olive oil may exert a beneficial effect on the risk of coronary disease.
• International comparisons, with the pioneering results of the Seven Countries Study, also support this hypothesis.
• In this hospital-based matched case-control study, conducted in Navarre (Spain), the relative risk reduction for myocardial infarction was greater than 75% for participants in the highest quintile of olive oil consumption (median = 54 g/day) versus the first quintile (median = 7 g/day), after multivariate adjustment for a wide array of dietary and non-dietary confounders.
• Some inconsistencies remain: previous case-control studies in Italy and Greece did not find any association, and a small randomized trial on coronary patients conducted by Rose almost 40 years ago was also negative for olive oil, and even harmful for corn oil.
• There is a need for large, prospective cohort studies conducted in Mediterranean countries where high and heterogeneous consumption of olive oil exists.
There is no single Mediterranean diet. The traditional diets of the countries surrounding the Mediterranean, however, share a number of common features. They are (or were) plant-based with olive oil as the principal fat. 1 These diets appear to be healthful. The Seven Countries study showed that Mediterranean populations studied in the 1960s and 1970s had low rates of death attributed to coronary heart disease and low rates of death from all causes in middle age. 2 Furthermore, the favourable health experience of Greek migrants to Australia and the declines in death rates attributed to coronary disease in many Mediterranean countries in the face of a less traditional diet suggest that it may even be possible to improve on this tried and tested cultural recipe for health. [3] [4] [5] The challenge is to tease out (if possible) the healthful features of the Mediterranean diets. 6 This is important for several reasons. First, while some of us have sufficient resources to eat more Mediterranean diets there are concerns that many who are less privileged do not. 7 Second, the widespread adoption of Mediterranean diets (and how far this can be altered to take account of what can be grown locally) has implications for agriculture 8 and for the environment. 9 Thus, to inform individual choices and policy formulation, it is important to try and unpick the Mediterranean advantage.
The study by Fernández-Jarne and colleagues represents an attempt to do just this. 10 They report a hospital-based casecontrol study of 171 cases of first acute myocardial infarction and age-and sex-matched controls they carried out in a Spanish population to examine the association with olive oil intake. There was marked heterogeneity of olive oil consumption (assessed by food frequency questionnaire) in this population-54 g per day in the top quintile versus 7 g per day in the bottom quintile in the controls. While those controls in the top quintile for olive oil consumption were more likely to be married, to eat a more plant-based diet and consume more alcohol they were also more likely to smoke and to be diabetic. After adjustment for a number of confounders the odds ratio in the top quintile was 0.18 (95% CI : 0.05-0.63). Though the test for trend was statistically significant (P = 0.03) there was no clear dose response. This study was small and these findings are not consistent with the results of other studies in Mediterranean populations. A case-control study in Italian women found no association with oil consumption 11 and a case-control study in Greece found no association with monounsaturated fat intake. 12 Nevertheless, it does raise the possibility that olive oil is a particularly important component of the Mediterranean diet. While cohort studies such as the European Prospective Investigation into Cancer (EPIC) 13 may be able to confirm whether this observational association exists in prospectively collected data, ultimately trials will be required to establish whether an important causal relationship exists.
Though there have been no large trials of olive oil supplementation specifically there are several other trials that have tested various aspects of Mediterranean diets. One secondary prevention trial of advice to eat a more Mediterranean diet was carried out in France. 14 In this trial 605 middle-aged people with a recent myocardial infarction were randomized to receive advice to eat a Mediterranean diet (more bread, more vegetables, more fruit, more fish, and less meat), and to replace butter and cream with rapeseed margarine. After 27 months the trial was stopped prematurely because of better outcomes in the intervention group. There were 20 deaths in the control group and 8 in the intervention group. The adjusted risk of death from all causes was 0.30 (95% CI : 0.11-0.82). These findings have not been replicated.
Traditional Mediterranean diets contain modest amounts of fish. 1 Two large trials of advice to eat more fish or fish oil supplements (and thus more n-3 fatty acids) 15, 16 have reported a reduced risk of all-cause mortality in people with existing coronary heart disease. The pooled rate ratio for dietary fish or fish oil on total mortality based largely on the results of these two trials was 0.83 (95% CI : 0.73-0.94, with no significant heterogeneity). 17 A long-term follow-up of the Diet and Re-infarction Trial (DART1), however, failed to show any substantial longterm survival benefit. 18 Furthermore, the results of a large randomized trial of fish advice in men with angina, the Diet and Angina Randomised Trial (DART2), are not consistent with the results from these previous trials. 19 The Mediterranean diets being plant-based are rich in antioxidants. 6 The results of trials of antioxidant supplementation (such as β-carotene, vitamin E and vitamin C) have, however, been disappointingly null. [20] [21] [22] [23] In conclusion, a more profitable epidemiological approach to exploring the Mediterranean advantage may be to move away from constituent-based analyses and experiments and to carry out food-based analyses (such as the one reported by Fernández-Jarne and colleagues) in the first instance and to follow these up with trials of whole food modification or dietary advice.
